Vaccines, our shared responsibility.
The Developing Countries Vaccine Manufacturers' Network (DCVMN) held its fifteenth annual meeting from October 27-29, 2014, New Delhi, India. The DCVMN, together with the co-organizing institution Panacea Biotec, welcomed over 240 delegates representing high-profile governmental and nongovernmental global health organizations from 36 countries. Over the three-day meeting, attendees exchanged information about their efforts to achieve their shared goal of preventing death and disability from known and emerging infectious diseases. Special praise was extended to all stakeholders involved in the success of polio eradication in South East Asia and highlighted challenges in vaccine supply for measles-rubella immunization over the coming decades. Innovative vaccines and vaccine delivery technologies indicated creative solutions for achieving global immunization goals. Discussions were focused on three major themes including regulatory challenges for developing countries that may be overcome with better communication; global collaborations and partnerships for leveraging investments and enable uninterrupted supply of affordable and suitable vaccines; and leading innovation in vaccines difficult to develop, such as dengue, Chikungunya, typhoid-conjugated and EV71, and needle-free technologies that may speed up vaccine delivery. Moving further into the Decade of Vaccines, participants renewed their commitment to shared responsibility toward a world free of vaccine-preventable diseases.
DCVMN International, Route de Crassier 7, 1262 Nyon, Switzerland. Electronic address: s.pagliusi@dcvmn.org.
Sonia
S
Pagliusi
Panacea Biotec Ltd., B-1, Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi 110044, India. Electronic address: rishabhjain@panaceabiotec.com.
Rishabh
R
Jain
Panacea Biotec Ltd., B-1, Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi 110044, India. Electronic address: rksuri@panaceabiotec.com.
Rajinder Kumar
RK
Suri
D003140:Communicable Disease Control / Q000379:methods*; D003141:Communicable Diseases / Q000453:epidemiology* / Q000401:mortality*; D003906:Developing Countries; D006801:Humans; D014611:Vaccination / Q000379:methods*; D014612:Vaccines / Q000276:immunology* / Q000302:isolation & purification* / Q000600:supply & distribution
D014612:Vaccines
Collaboration; Developing countries; Immunization; Innovation; Vaccines